Association between the Melatonin Receptor 1B Gene Polymorphism on the Risk of Type 2 Diabetes, Impaired Glucose Regulation: A Meta-Analysis

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Xia, Qing ^a   Chen, Zi Xian ^a   Wang, Yi Chao ^a   Ma, Yu Shui ^a   Zhang, Feng ^a   Che, Wu ^a   Fu, Da ^a   Wang, Xiao Feng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MELATONIN 1 RECEPTOR; MELATONIN 1B RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ASIAN; CAUCASIAN; CONFIDENCE INTERVAL; DOMINANT INHERITANCE; ETHNIC DIFFERENCE; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MTNR1B GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PREDICTION; RECESSIVE INHERITANCE; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC ERROR; SYSTEMATIC REVIEW;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DATABASES, BIBLIOGRAPHIC; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLUCOSE; HUMANS; INSULIN; MALE; MODELS, GENETIC; POLYMORPHISM, GENETIC; RECEPTOR, MELATONIN, MT1; RISK;

EID: 84870597076     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050107     Document Type: Article

References (49)

1. Watanabe RM, Valle T, Hauser ER, Ghosh S, Eriksson J, et al. (1999) Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered 49: 159-168.
2. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, et al. (2009) Variants in MTNR1B influence fasting glucose levels. Nat Genet 41: 77-81.
3. Lyssenko V, Nagorny CL, Erdos MR, Wierup N, Jonsson A, et al. (2009) Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 41: 82-88.
4. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, Sparso T, Holmkvist J, et al. (2009) A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 41: 89-94.
5. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116.
6. Bouatia-Naji N, Rocheleau G, Van Lommel L, Lemaire K, Schuit F, et al. (2008) A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science 320: 1085-1088.
7. Peschke E, Bach AG, Muhlbauer E, (2006) Parallel signaling pathways of melatonin in the pancreatic beta-cell. J Pineal Res 40: 184-191.
8. Mulder H, Nagorny CL, Lyssenko V, Groop L, (2009) Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene. Diabetologia 52: 1240-1249.
9. Muhlbauer E, Gross E, Labucay K, Wolgast S, Peschke E, (2009) Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose. Eur J Pharmacol 606: 61-71.
10. Wang Y, Martin CC, Oeser JK, Sarkar S, McGuinness OP, et al. (2007) Deletion of the gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen results in a mild metabolic phenotype. Diabetologia 50: 774-778.
11. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
12. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
13. Thompson SG, Sharp SJ, (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18: 2693-2708.
14. Woolf B, (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19: 251-253.
15. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
16. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
17. Staiger H, Machicao F, Schäfer SA, Kirchhoff K, Kantartzis K, et al. (2008) Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS One 3: e3962.
18. Sparsø T, Bonnefond A, Andersson E, Bouatia-Naji N, Holmkvist J, et al. (2009) G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Diabetes 58: 1450-1456.
19. Rönn T, Wen J, Yang Z, Lu B, Du Y, et al. (2009) A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia 52: 830-833.
20. Reiling E, van 't Riet E, Groenewoud MJ, Welschen LM, van Hove EC, et al. (2009) Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk. Diabetologia 52: 1866-1870.
21. Tam CH, Ho JS, Wang Y, Lee HM, Lam VK, et al. (2010) Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects. PLoS One 5: e11428.
22. Liu C, Wu Y, Li H, Qi Q, Langenberg C, et al. (2010) MTNR1B rs10830963 is associated with fasting plasma glucose, HbA1C and impaired beta-cell function in Chinese Hans from Shanghai. BMC Med Genet 11: 59.
23. Simonis-Bik AM, Nijpels G, van Haeften TW, Houwing-Duistermaat JJ, Boomsma DI, et al. (2010) Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes 59: 293-301.
24. Xu M, Bi Y, Xu Y, Yu B, Huang Y, et al. (2010) Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studies. PLoS One 5: e14022.
25. Hu C, Zhang R, Wang C, Yu W, Lu J, et al. (2010) Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion. PLoS One 5: e11761.
26. Kan MY, Zhou DZ, Zhang D, Zhang Z, Chen Z, et al. (2010) Two susceptible diabetogenic variants near/in MTNR1B are associated with fasting plasma glucose in a Han Chinese cohort. Diabet Med 27: 598-602.
27. Rees SD, Hydrie MZ, O'Hare JP, Kumar S, Shera AS, et al. (2011) Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South Asians: ADCY5 and GLIS3 variants may predispose to type 2 diabetes. PLoS One 6: e24710.
28. Dietrich K, Birkmeier S, Schleinitz D, Breitfeld J, Enigk B, et al. (2011) Association and evolutionary studies of the melatonin receptor 1B gene (MTNR1B) in the self-contained population of Sorbs from Germany. Diabet Med 28: 1373-1380.
29. Been LF, Hatfield JL, Shankar A, Aston CE, Ralhan S, et al. (2011) A low frequency variant within the GWAS locus of MTNR1B affects fasting glucose concentrations: Genetic risk is modulated by obesity. Nutr Metab Cardiovasc Dis doi:10.1016/j.numecd.2011.01.006.
30. Ling Y, Li X, Gu Q, Chen H, Lu D, Gao X, (2011) A common polymorphism rs3781637 in MTNR1B is associated with type 2 diabetes and lipids levels in Han Chinese individuals. Cardiovasc Diabetol 10: 27.
31. Olsson L, Pettersen E, Ahlbom A, Carlsson S, Midthjell K, et al. (2011) No effect by the common gene variant rs10830963 of the melatonin receptor 1B on the association between sleep disturbances and type 2 diabetes: results from the Nord-Trondelag Health Study. Diabetologia 54: 1375-1378.
32. Ohshige T, Iwata M, Omori S, Tanaka Y, Hirose H, et al. (2011) Association of new loci identified in European genome-wide association studies with susceptibility to type 2 diabetes in the Japanese. PLoS One 6: e26911.
33. Renström F, Shungin D, Johansson I, (2011) MAGIC Investigators (2011) Florez JC, et al. (2011) Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: Ten-year follow-up of the GLACIER study. Diabetes 60: 345-354.
34. Song JY, Wang HJ, Ma J, Xu ZY, Hinney A, et al. (2011) Association of the rs10830963 polymorphism in MTNR1B with fasting glucose levels in Chinese children and adolescents. Obes Facts 4: 197-203.
35. Tabara Y, Osawa H, Kawamoto R, Onuma H, Shimizu I, et al. (2011) Genotype risk score of common susceptible variants for prediction of type 2 diabetes mellitus in Japanese: the Shimanami Health Promoting Program (J-SHIPP study). Development of type 2 diabetes mellitus and genotype risk score. Metabolism 60: 1634-1640.
36. Liu Y, Zhou L, Xie XM, Yang Z, (2012) The correlation of MTNR1B gene polymorphism with type 2 diabetes mellitus in Ningxia Han population. Zhongguo Lao Nian Xue Zazhi 6: 111-1121.
37. Walford GA, Green T, Neale B, Isakova T, Rotter JI, et al. (2012) Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism. Diabetologia 55: 331-339.
38. Konturek SJ, Konturek PC, Brzozowski T, Bubenik GA, (2007) Role of melatonin in upper gastrointestinal tract. J Physiol Pharmacol 58 (Suppl 6):: 23-52.
39. Jaworek J, Nawrot-Porabka K, Leja-Szpak A, Bonior J, Szklarczyk J, et al. (2007) Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J Physiol Pharmacol 58 (Suppl 6):: 65-80.
40. Knutson KL, Spiegel K, Penev P, Van Cauter E, (2007) The metabolic consequences of sleep deprivation. Sleep Med Rev 11: 163-178.
41. Laposky AD, Bass J, Kohsaka A, Turek FW, (2008) Sleep and circadian rhythms: key components in the regulation of energy metabolism. FEBS Lett 582: 142-151.
42. Peschke E, (2008) Melatonin, endocrine pancreas and diabetes. J Pineal Res 44: 26-40.
43. Ramracheya RD, Muller DS, Squires PE, Brereton H, Sugden D, et al. (2008) Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res 44: 273-279.
44. Peschke E, Stumpf I, Bazwinsky I, Litvak L, Dralle H, et al. (2007) Melatonin and type 2 diabetes - a possible link? J Pineal Res 42: 350-358.
45. Bonnefond A, Clément N, Fawcett K, Yengo L, Vaillant E, et al. (2012) Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 44: 297-301.
46. Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, et al. (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78: 305-312.
47. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, et al. (1988) The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319: 1500-1506.
48. Wang J, Kuusisto J, Vänttinen M, Kuulasmaa T, Lindström J, et al. (2007) Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia 50: 1192-1200.
49. Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, et al. (2010) Genetic variation in GIPR influences glucose and insulin responses to an oral glucose challenge. Nat Genet 42: 142-148.